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Abstract
Objective: To determine predictors of focal to bilateral tonic-clonic seizures 
(FBTCS) during video–electroencephalography (EEG) monitoring (VEM).
Methods: All adult patients undergoing presurgical VEM from 2014 to 2015 in the 
department of epileptology were eligible (N = 229). Those with refractory focal epi-
lepsy and epileptic seizures recorded during VEM were analyzed (N = 188, Group 
1). To assess the effects of antiepileptic drug (AED) taper, the total AED load was 
calculated as the sum of the ratios of prescribed daily dose and defined daily dose 
of all AEDs per VEM day and was correlated with the occurrence of focal seizures 
without bilateral tonic-clonic seizures (FwoBTCS) and FBTCS. To validate the find-
ings, data of patients undergoing VEM in 2004 and 2005 (Group 2, eligible N = 243, 
analyzed N = 203) were also investigated.
Results: In Group 1, 53 patients had FBTCS and 135 patients had exclusively 
FwoBTCS during VEM. Reduced AED load at seizure onset was the most impor-
tant modifiable risk factor for FBTCS (receiver-operating characteristic [ROC]: area 
under the curve [AUC] = 0.78). Furthermore, the risk of FBTCS varied with the 
history and frequency of FBTCS prior to VEM. For instance, patients had a 50% risk 
of FBTCS by reducing the AED load to ~20% when no information about history 
of FBTCS was taken into account, to ~30% when a positive history of FBTCS was 
taken into account, and to ~50% when a high frequency of FBTCS prior to VEM was 
taken into account. These findings were largely replicated in Group 2 (59 patients 
with FBTCS and 144 exclusively with FwoBTCS).
Significance: The risk of FTBCS during VEM depends on the history and frequency 
of FTBCS prior to VEM and is particularly associated with the extent of AED reduc-
tion. Our data underscore the need for appropriate tapering regimens in VEM units.
K E Y W O R D S
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1 |  INTRODUCTION
Video–electroencephalography (EEG) monitoring (VEM) is 
a widely used method in the diagnostic assessment for epi-
lepsy surgery. To facilitate the occurrence of focal seizures, 
it is common practice in epilepsy-monitoring units (EMUs) 
to taper off antiepileptic drugs (AEDs). At present, specific 
protocols for AED load reductions are lacking in most epi-
lepsy centers.1,2 During VEM, a proportion of 24%-57% 
of patients develop focal to bilateral tonic-clonic seizures 
(FBTCS).3 Some semiologic signs (eg, forced deviation of 
head and eyes contralateral to the putative hemisphere of 
seizure onset) during FBTCS may provide additional infor-
mation in the presurgical assessment. However, FBTCS are 
usually not intended, as they are associated with significant 
risks to patients’ safety. Seizure-related falls occur in 1%–
20% of patients in EMUs, sometimes with severe injuries 
due to FBTCS.4‒6 Furthermore, FBTCS are associated with 
apnea and subsequent hypoxemia, in some cases leading to 
bradycardia, asystole, and sudden unexpected death in epi-
lepsy (SUDEP).7,8 Although FBTCS in EMUs are likely to 
be detected earlier than in other environments, they are none-
theless a major source of complications. Therefore, it would 
be of considerable value to identify factors that modify the 
risk of their occurrence.
We hypothesize that the risk of FBTCS during VEM is 
influenced by the patients’ history and frequency of previous 
FBTCS and, more importantly, by AED load reduction. To 
investigate these hypotheses, various individual and clinical 
factors as well as daily AED doses were retrospectively as-
sessed in two groups of patients who underwent VEM for the 
evaluation of epilepsy surgery.
2 |  METHODS
2.1 | Study design and population
The study investigated risk factors for FBTCS during VEM 
in two cohorts of patients, assessed for possible epilepsy sur-
gery in an EMU, separated by one decade. Strengthening the 
reporting of observational studies in Epidemiology criteria 
for case-control studies, the RECORD statement for obser-
vational studies using routinely collected health data, and 
the STARD list for reporting diagnostic accuracy studies 
were applied, according to the EQUATOR reporting guide-
lines (available at http://www.equat or-netwo rk.org, accessed 
12/10/2019).
We primarily investigated consecutive adult (≥18 years) 
patients with refractory focal epilepsy who had seizures 
during VEM in the EMU of the University Hospital Bonn, 
Germany, Department of Epileptology in the years 2014 and 
2015. In a second step, patients of 2004 and 2005 were also 
analyzed, to test the reliability of our results. All patients who 
underwent VEM for presurgical assessment in the respective 
periods were examined for eligibility. The standard battery 
of presurgical assessment includes cerebral magnetic reso-
nance imaging (MRI), VEM using noninvasive scalp EEG 
or invasive EEG, and neuropsychological testing. In VEM, 
live video is constantly recorded to correlate patient's be-
havior and semiological signs with the regional onset and 
propagation of seizure activity. Patients with idiopathic gen-
eralized epilepsy syndromes or psychogenic nonepileptic 
seizures only were excluded. We also excluded patients with 
incomplete data records, patients without any seizure during 
VEM, and multiple cases of the same patients to guarantee 
meaningful statistical analysis. Furthermore, patients were 
excluded who did not take any AED at all or AED without 
available defined daily dose (DDD) values. In addition, pa-
tients whose seizures could not be categorized as FwoBTCS 
or FBTCS were excluded.
2.2 | Outcome measures
Patients with focal without bilateral tonic-clonic seizures 
(FwoBTCS) only during VEM served as controls for patients 
with at least one FBTCS during VEM. The AED load for each 
day during VEM was assessed as the sum of the ratios of pre-
scribed daily dose (PDD) per DDD for all AEDs of the pa-
tient, allowing for interindividual comparisons of total drug 
loads, irrespective of specific combinations of substances.9 
The DDD for individual AEDs are published by the World 
Health Organization (WHO) and are accessible online.10‒13 
Age, sex, type of EEG recording, history of FBTCS, frequency 
of FBTCS (with “high frequency” being defined as occurrence 
of at least one FBTCS within the last 3 months prior to VEM, 
or an average of at least one FBTCS per 3 months over the 
last 12 months prior to VEM and clusters over one day being 
Key points
• Potential risk factors of focal to bilateral tonic-
clonic seizures (FBTCS) during video–electro-
encephalography (EEG) monitoring (VEM) were 
investigated.
• Important predisposing factors were history and 
frequency of FBTCS prior to VEM.
• The antiepileptic drug (AED) load reduction was 
the most important modifiable risk factor for 
FBTCS during VEM.
• The risk of potentially deleterious FBTCS might 
be reduced by appropriate AED tapering regimens 
according to the individual seizure history.
   | 491PENSEL Et aL.
treated as one seizure), MRI lesions, localization of seizure 
onset, state of vigilance at seizure onset, the AED load at VEM 
start and at the time point of the first FwoBTCS or first FBTCS 
(absolute and relative to VEM start), as well as the velocity of 
AED reduction to first seizure (relative change of AED load 
per day) were assessed (Table S1). Status epilepticus was not 
an outcome measure and we did not assess history of status 
epilepticus as a possible risk factor for FBTCS.
2.3 | Data and statistical methods
Medical records were reviewed and relevant data were ex-
tracted and pseudonymized. The investigators had full access 
to the data of all patients. Possible bias might arise from taper-
ing regimens that were not standardized but depended on the 
individual decisions of the treating physicians. Furthermore, 
tapering regimens might have been different for specific types 
of AED. To circumvent these sources of bias, we analyzed data 
from two patient groups separated by one decade with other 
treating physicians and an expectedly different distribution of 
AED. The study size was determined by the number of patients 
investigated with the method of VEM during the respective 
time intervals. Analyses were performed using IBM SPSS 25. 
Group statistics compared patients who had FwoBTCS only (a) 
with those who developed at least one FBTCS (b) during VEM, 
using Student's t tests and χ2 tests (or Fischer's exact tests) at a 
significance level of α = 0.05. Furthermore, receiver-operating 
characteristic (ROC) and hierarchical logistic regressions were 
calculated for specific predictors. In ROC, the area under the 
curve (AUC) determines the accuracy of the respective predic-
tors. In the logistic regression, the expected value of the binary 
variable “Occurrence of FBTCS” is regressed on the logistic 
function of a linear combination of predictors. Thereby, the lin-
ear combination of predictors is mapped to the interval from 0 
to 1, and thus the predicted value denotes the probability that an 
FBTCS occurs:
P(“Occurrence of FBTCS”) = exp(β0 + β1X1+ … +βkXk)/
[1 + exp (β0 + β1X1+ … +βkXk)].
The regression model's fit is indicated by the deviance, 
which under the null hypothesis follows a χ2 distribution with k 
(number of predictors) degrees of freedom. In the same vein, a 
significant difference in deviance between nested models indi-
cates that the additional predictors in the more complex model 
critically contribute to the prediction of the dependent vari-
able. Averaged group data are given as mean ± SD.
This retrospective audit of data collected during standard 
clinical care was approved by the local medical ethics com-
mittee (Ethikkommission an der Medizinischen Fakultät der 
Rheinischen Friedrich-Wilhelms-Universität Bonn, No. 352/12).
3 |  RESULTS
3.1 | Study population
In a first step, 229 adult patients undergoing VEM for 
pre-surgical assessment in the years 2014 and 2015 were 
examined for eligibility (Figure 1). A total of 188 patients 
were included in the final analysis (Group 1), of whom 
53 had FBTCS (subgroup 1b, absolute AED load at VEM 
start = 3.03 ± 1.10) and 135 exclusively FwoBTCS (sub-
group 1a, absolute AED load at VEM start = 3.58 ± 1.58) 
during VEM, resulting in 2.55 controls per case. In a sec-
ond step, 243 adult patients who underwent presurgical 
assessment 10 years before (years 2004 and 2005) in the 
same EMU were also analyzed (Group 2). A total of 203 
individuals were included in the final analyses of Group 
2, comprising 59 patients with FBTCS (subgroup 2b, ab-
solute AED load at VEM start  =  2.49  ±  1.38) and 144 
with only FwoBTCS during VEM (subgroup 2a, absolute 
AED load at VEM start  =  2.79  ±  1.63), which equals 
2.44 controls per case. Group 1 and Group 2 did not dif-
fer significantly in age (t = −1.50, df = 389, ns), or sex F I G U R E  1  Inclusion and exclusion criteria
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(χ2 = 0.82, df = 1, ns), yet distribution of specific AED 
was significantly different, Fisher's exact test  =  99.86, 
df = 25, P ≤ .001 (Figure S1).
3.2 | Predictors of FBTCS during VEM: 
Receiver-operating characteristics
Predictors were only considered reliable if their values 
were significantly different in the seizure-type–related sub-
groups (a and b) of both patient groups (1 and 2). Univariate 
analyses revealed that “Positive history of FBTCS,” “High 
frequency of previous FBTCS,” “Velocity of AED load 
reduction,” and “AED load at first seizure” (absolute and 
relative to VEM start) were significantly associated with 
the occurrence of FBTCS during VEM in both groups of 
patients (Table S2), whereas the other predictors were not 
(Table S3).
The reliable predictors include non-modifiable and mod-
ifiable factors. By comparing the predictive power of the re-
liable predictors using ROC analyses, “Relative AED load at 
first seizure” emerged as the best modifiable predictor (Table 
1, Figure S2).
3.3 | Predictors of FBTCS during VEM: 
Logistic regressions
To further evaluate the impact of the aforementioned 
modifiable factors, the association between occurrence of 
FBTCS during VEM and extent (given in steps of 10%) as 
well as velocity (given in steps of 10% per day) of AED 
load reduction were stratified according to the history and 
frequency of FBTCS prior to VEM, using hierarchical 
logistic regression analyses for three different scenarios 
(Tables 2‒4). The chosen scenarios are common in every-
day practice, where the clinician is challenged to define an 
AED tapering regimen based on the anamnestic informa-
tion given by the patient.
In Scenario 1 (Table 2), history and frequency of FBTCS prior 
to VEM are neglected, and only modifiable predictors (“AED 
load reduction” and “Velocity of reduction”) are accounted for. 
Taken individually, both of these factors are significantly pre-
dicting the occurrence of FBTCS (see χ2 and RN
2 in models 
1.1.1 and 1.1.2). Here, exp (β) indicates the multiplicative factor 
by which the odds of the dependent variable P(“Occurrence of 
FBTCS”) change when the respective predictor value changes 
by one unit (AED load reduction of 10%, velocity of reduction 
of 10% per day), that is, the odds ratio. It is important to note 
that the two modifiable predictors (“AED load reduction” and 
“Velocity of reduction”) are significantly correlated with each 
other (Group 1: r = .79***, Group 2: r = .64***). Therefore, 
we also calculated a combined model (Model 1.2), where both 
predictors are included together. In comparison to “Velocity of 
AED load reduction” alone, the addition of “AED load reduc-
tion” significantly improved the predictive strength (Model 1.2 
vs Model 1.1.1), whereas the combined model did not increase 
the predictive strength compared to “AED load reduction” alone 
(Model 1.2 vs Model 1.1.2). This finding suggests that “AED 
load reduction” is a much stronger predictor than “Velocity of 
reduction,” of which the influence in the combined analysis is 
no longer significant. In the combined analysis (Model 1.2), the 
odds ratio, exp (β), for every 10% reduction per day is calcu-
lated at 0.99 in Group 2, indicating no meaningful influence of 
“Velocity of reduction” on FBTCS occurrence at all. In Group 
1, the estimation is clearly below 1.00, exp (β) = 0.58, sug-
gesting even a negative influence on FBTCS occurrence, al-
though not a significant one. Taken together, one can conclude 
that “AED load reduction” is a better predictor for FBTCS than 
“Velocity of reduction.”
In Scenario 2, the same analyses were performed after 
inclusion of the information on history of FBTCS as a 
non-modifiable factor (Table 3). In Group 1, a positive his-
tory of FBTCS (Model 2.1) already significantly increases 
the odds for FBTCS by a factor of exp (β) = 8.05 (odds ratio 
[OR]), corresponding to a relative risk (RR) of 5.47. Similarly, 
this holds also true for Group 2 (OR  =  5.41, RR  =  3.82). 
However, by adding the information on AED load reduction, 
T A B L E  1  Receiver-operating characteristic (ROC): accuracy of 
reliable predictors for FBTCS during VEMa
  N AUC P 95% CI
Non-modifiable predictors of FBTCS during VEM
Positive history of FBTCSb
Group 1 (2014/15) 182 0.63 .004 0.55 0.72
Group 2 (2004/05) 200 0.63 .005 0.55 0.71
High frequency of previous FBTCSc
Group 1 (2014/15) 139 0.79 ≤.001 0.69 0.88
Group 2 (2004/05) 144 0.65 .006 0.54 0.76
Modifiable factors of FBTCS during VEM
Velocity of AED load reduction
Group 1 (2014/15) 188 0.67 ≤.001 0.59 0.75
Group 2 (2004/05) 203 0.69 ≤.001 0.62 0.76
Absolute AED load at first seizure
Group 1 (2014/15) 188 0.78 ≤.001 0.72 0.85
Group 2 (2004/05) 203 0.72 ≤.001 0.65 0.79
Relative AED load at first seizure
Group 1 (2014/15) 188 0.78 ≤.001 0.71 0.85
Group 2 (2004/05) 203 0.79 ≤.001 0.73 0.85
Null hypothesis 0.50  
aThe null hypothesis describes a predictor at chance level. 
bOnly patients with data regarding history of FBTCS prior to VEM. 
cOnly patients with data regarding frequency of FBTCS prior to VEM. 
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T A B L E  2  Scenario 1. Logistic regression without information on history or frequency of FBTCS
Predictors







exp (β) [95% CI] ≙ 
Odds ratio (OR) χ2 (df) RN
2
exp (β) [95% CI] ≙ 
Odds Ratio (OR)
Model 1.1.1
Constant 14.84 (1)*** 0.11 0.16*** 13.88 (1)*** 0.09 0.22***
Velocity of reduction 2.46 [1.52, 3.99]*** 1.63 [1.22, 2.18]***
Model 1.1.2
Constant 42.04 (1)*** 0.29 0.07*** 43.09 (1)*** 0.27 0.09***
AED load reduction 1.38 [1.24, 1.55]*** 1.36 [1.23, 1.51***
Model 1.2
Constant 43.71 (2)*** 0.30 0.08*** 43.09 (2)*** 0.27 0.09
Velocity of reduction 0.58 [0.25, 1.35] ns 0.99 [0.73, 1.36] ns
AED load reduction 1.48 [1.26, 1.74]*** 1.36 [1.21, 1.54]***
Model comparisons 1.2 vs 1.1.1 1.2 vs 1.1.2 1.2 vs 1.1.1 1.2 vs 1.1.2
χ2 (df) 28.87 (1)*** 1.67 (1) ns 29.22 (1)*** 0.00 (1), ns
Δ RN
2 0.19 0.01 0.18 0.00
Note: RN
2 = Nagelkerke (pseudo-) R2.
AED load reduction [10% reduction of PDD/DDD].
Velocity of reduction [10% reduction of (PDD/DDD)/d].
***P ≤ .001; ns = not significant. 
T A B L E  3  Scenario 2. Logistic regression including information on history of FBTCS
Predictors
Group 1 (2014/15) N = 182 Group 2 (2004/05) N = 200
χ2 (df) RN
2
exp (β) [95%CI] ≙ 
Odds Ratio (OR) χ2 (df) RN
2
exp (β) [95%CI] ≙ 
Odds Ratio (OR)
Model 2.1
Constant 17.73 (1)*** 0.13 0.07*** 15.54 (1) *** 0.11 0.10***
History of FBTCS 8.05 [2.37, 27.30]*** 5.41 [2.03, 14.43]***
Model 2.2.1
Constant 30.78 (2)*** 0.22 0.03*** 28.77 (2)*** 0.19 0.05***
History of FBTCS 8.31 [2.39, 28.94]*** 6.01 [2.08, 17.38]***
Velocity of reduction 2.47 [1.48, 4.15]***   1.61 [1.20, 2.15]**
Model 2.2.2
Constant 54.76 (2)*** 0.37 0.01*** 53.33 (2)*** 0.33 0.02***
History of FBTCS 8.51 [2.31, 31.35]** 5.16 [1.79, 14.92]**
AED load reduction 1.38 [1.23, 1.56]*** 1.36 [1.22, 1.51]***
Model 2.3
Constant 55.71 (3)*** 0.38 0.01*** 53.43 (3)*** 0.34 0.02***
History of FBTCS 8.18 [2.22, 30.23]** 5.25 [1.80, 15.27]**
Velocity of reduction 0.66 [0.29, 1.55] ns 1.05 [0.77, 1.44] ns 
AED load reduction 1.46 [1.24, 1.72]*** 1.35 [1.19, 1.52]***
Model 
comparisons
2.2.1 vs 2.1 2.2.2. vs 2.1 2.3 vs 2.2.1 2.3 vs 2.2.2 2.2.1 vs 2.1 2.2.2. vs 2.1 2.3 vs 2.2.1 2.3 vs 2.2.2
χ2 (df) 13.05 (1)*** 37.03 (1)*** 24.93 (1)*** 0.95 (1) ns 13.23 (1)*** 37.78 (1)*** 24.66 (1)*** 0.10 (1) ns 
Δ RN
2 0.09 0.24 0.15 0.01 0.08 0.23 0.14 0.00
** P ≤ .01; ***P ≤ .001; ns = not significant. 
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the predictive power for occurrence of FBTCS even signifi-
cantly improves (Model 2.2.2 vs Model 2.1), demonstrating 
that the risk of FBTCS to occur during VEM is predicted by 
AED load reduction beyond the patients’ history of FBTCS. 
Whereas “Velocity of reduction” is also significantly increas-
ing the predictive quality over “History of FBTCS” (Model 
2.2.1), in the combined analysis with “AED load reduction” 
(Model 2.3), again, its influence is no longer significant. Of 
the patients with a negative history of FBTCS, the fraction 
that developed FBTCS during VEM was 6.67% in Group 1 (3 
of 45) and 9.43% in Group 2 (5 of 53), see Table S1. Logistic 
regressions revealed that also in these patients, “AED load 
reduction” was a significant predictor for FBTCS occurrence 
and excelled “Velocity of reduction” (Table 5).
The analysis was further refined in Scenario 3 for patients 
with a positive history of FBTCS by including “Frequency of 
previous FBTCS” into the model (Table 4). In this scenario, high 
frequency of previous FBTCS is associated with a significantly 
greater risk of FBTCS during VEM in both groups (Group 1: 
OR = 10.54, RR = 5.18; Group 2: OR = 2.51, RR = 1.84). 
Again, “AED load reduction” as well as “Velocity of reduction” 
increase the predictive quality of the model, but in the com-
bined analysis (Model 3.3) only “AED load reduction” plays 
an important role while “Velocity of reduction” no longer does.
We also aimed at quantifying the AED load reductions, 
which facilitate occurrence of FBTCS. To that end, we cal-
culated the specific values for “AED load reduction” at a 
50% probability of FBTCS (and a corresponding 50% prob-
ability of an FwoBTCS), based on the estimations of the 
combined models in the three scenarios. Because “Velocity 
of reduction” was shown to be less important than the ac-
tual AED load reduction, the following numbers are based 
on the observed mean levels of velocity. According to the 
estimation of Model 1.2, the probability of an FBTCS 
in Group 1 amounts to 50% when the relative AED load 
is reduced to 24.45% of the initial AED load at a mean 
T A B L E  4  Scenario 3. Logistic regression including information on frequency of previous FBTCS
Predictors
Group 1 (2014/15) N = 94 Group 2 (2004/05) N = 93
χ2 (df) RN
2
exp (β) [95%CI] ≙ Odds 
Ratio (OR) χ2 (df) RN
2





0.30 0.12*** 4.26 (1)* 0.06 0.32***
Frequency of previous 
FBTCS




0.38 0.04*** 8.98 (2)* 0.13 0.16***
Frequency of previous 
FBTCS
11.06 [3.54, 34.59]*** 2.43 [0.98, 6.04] ns 




0.45 0.02*** 19.42 (2)*** 0.26 0.06***
Frequency of previous 
FBTCS
11.38 [3.48, 37.19]*** 3.22 [1.19, 8.70]*




0.45 0.02*** 19.54 (3)*** 0.26 0.07***
Frequency of previous 
FBTCS
11.38 [3.48, 37.20]*** 3.31 [1.20, 9.10]*
Velocity of reduction 0.99 [0.30, 3.29] ns 0.89 [0.47, 1.70] ns 
AED load reduction 1.33 [1.06, 1.66]* 1.35 [1.11, 1.64]**
Model 
comparisons
3.2.1 vs 3.1 3.2.2 vs 3.1 3.3 
vs 
3.2.1
3.3 vs 3.2.2 3.2.1 vs 3.1 3.2.2 
vs 
3.1
3.3 vs 3.2.1 3.3 vs 3.2.2
χ2 (df) 6.66 (1)* 13.46 (1)*** 6.80 (1)** 0.00 (1) ns 4.73 (1)* 15.16 (1)*** 10.56 (1)** 0.12 (1) ns 
Δ RN
2 0.07 0.14 0.07 . 00 0.07 0.20 0.14 0.00
*P ≤ .05; ** P ≤ .01; ***P ≤ .001; ns = not significant. 
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velocity of reduction of 8.69% per day. The analysis of 
Group 2 yields similar results, that is, an AED load reduc-
tion to 20.34% is associated with a probability of 50% for an 
FBTCS to occur during VEM at a mean velocity of 12.15% 
per day. Respective calculations were also performed for 
Models 2.3 and 3.3, resulting in thresholds for AED load 
reduction that represent a probability of 50% for an FBTCS 
under defined circumstances of history and frequency of 
FBTCS (see Table 5; see also Table S4 for lower FBTCS 
probabilities). No meaningful AED load reduction thresh-
olds could be assessed for patients with a known negative 
history of FBTCS or a positive history but low frequency 
of FBTCS prior to VEM, due to an insufficient number of 
these specific cases.
4 |  DISCUSSION
4.1 | Key findings
In two different patient groups separated by a decade, the 
occurrence of FBTCS during VEM depended on the pa-
tient's history and frequency of FBTCS prior to VEM and 
was strongly influenced by the extent of AED reduction 
during VEM. Crucially, although the amount and the rate 
of AED load reduction both mattered, the amount of reduc-
tion was shown to be a better predictor, even when taking 
into account history and frequency of previous FBTCS. 
Our study suggests that the risk of potentially deleterious 
FBTCS in an EMU is associated with AED load reduction 
and underscores the need for prospectively tested tapering 
protocols.
4.2 | Limitations
Our retrospective clinical study comes with limitations. 
First, AED load reduction regimens were not standard-
ized, but depended on the individual decisions of the 
treating physicians and might have been unsystematically 
influenced by the patients’ anamnestic information on 
prior FBTCS. Second, tapering regimens might have been 
different for varying types of AEDs. Both aspects are im-
portant, as AEDs can significantly differ with respect to 
pharmacokinetics, mechanisms of action, and drug-drug 
interactions on the one hand and efficacy on control of 
FBTCS on the other hand.14 Because polypharmacothera-
pies varied considerably between individual patients, the 
effects of specific AED properties could not be system-
atically addressed. Being aware of these significant weak-
nesses, however, we have selected and analyzed two patient 
groups separated by a decade, assuming that the proportion 
of AEDs with distinct properties is very different (as shown 
in Figure S1) and that the treating physicians were differ-
ent. It is important to note that only those factors that were 
shown to correlate significantly with FBTCS occurrence 
during VEM in the two patient groups were considered as 
reliable. This approach appeared to us as a reasonable way 
of mitigate the effects of individual tapering regimens and 
AED properties. Therefore, we are confident that despite 
the above-mentioned limitations, our findings are solid 
and the conclusions clinically meaningful.
4.3 | Clinical implications
According to a recent survey, only about one-third of the 
responding EMUs had a written policy for AED with-
drawal during VEM.2 Knowledge of the specific impact 
of AED load reductions on complications during VEM is 
limited, and available data focus mainly on the occurrence 
of status epilepticus and seizure clusters.2,15,16 FBTCS 
are, however, far more frequent than status epilepticus 
during VEM3,6,16 and are significantly related to physical 
injuries5,17 and sudden unexpected death in epilepsy (or 
SUDEP)8. Previous studies dealing with FBTCS during 
VEM included between 54 and 151 patients, with 18% to 
57% of them having FBTCS during VEM.3,18‒23 The pro-
portion of people with FBTCS in our study (2014/15: 28%; 
2004/05: 29%) was largely within the range reported by 
T A B L E  5  Threshold values for AED load reductions
Scenario
Relative AED load
Mean ~Group 1 (2014/15) Group 2 (2004/05)
1: No information on prior FBTCS 24.45% 20.34% 22.39% 20%
2: Positive history of FBTCS prior to 
VEM
32.28% 28.37% 30.33% 30%
3: High frequency of FBTCS prior to 
VEM
52.50% 43.79% 48.15% 50%
Note: The results provide the actual AED load in relation to the AED load at VEM start (relative AED load) at the point of reduction when the probability for FBTCS 
becomes equal to the probability of FwoBTCS (0.5 or 50%), stratified by positive history and high frequency of FBTCS prior to VEM. Velocity of AED load reduction 
was fixed at the respective group mean value. Results are based on the estimated logistic regression models (Tables 2‒4).
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other studies. In previous studies, complete withdrawal of 
AED was associated with a twofold increase in FBTCS 
in VEM3 and occurred more frequently in patients with a 
positive history of FBTCS prior to VEM,24 yet risk factors 
were mostly not analyzed in greater detail or not validated 
in larger patient groups. However, a recent study investi-
gated the rate of FBTCS in a dichotomous relation to esti-
mated therapeutic vs nontherapeutic drug levels based on 
the patient's drug with the longest half-life, without finding 
significant effects.25
The present study provides a detailed approach and im-
plies certain levels of AED load reductions that are associated 
with an elevated risk of FBTCS during VEM, considering 
the patient’s history and frequency of previous FBTCS. As 
a quantitative measure we calculated the AED load of each 
VEM day and the relationship between the AED load at the 
day of seizure onset and the total AED load at VEM start, 
which allowed us to group and compare all patient data and 
to detect general patterns, irrespective of specific AED com-
binations.26‒28 Without taking into account information on 
FBTCS history, a 50% risk of an FBTCS during VEM was 
associated with a reduction to ~20% of the initial AED load. 
Taking into account a positive history of FBTCS, a 50% risk 
of an FBTCS during VEM was associated with a reduction to 
~30%, and with taking into account a high frequency of pre-
vious FBTCS, a 50% risk of an FBTCS during VEM was as-
sociated with a reduction to ~50% of the initial AED load (see 
Table 5). The velocity of AED reduction during VEM does 
not seem to contribute significantly to the risk of FBTCS, 
which is in line with previous studies.3,21 However, it must 
be acknowledged that due to the retrospective study design, a 
more important role of the tapering velocity cannot be ruled 
out, particularly concerning extremely high or extremely low 
rates of reduction, and may depend on specific AEDs.
In conclusion, we believe that our study provides practical 
estimates of AED load reductions that are associated with 
an elevated risk of FBTCS during VEM. Prospective studies 
are, however, recommended to corroborate our findings and 
to further investigate AED load reduction regimens for given 
drugs that specifically balance the risk of FBTCS during 
VEM and the length of the stay in an EMU.
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